These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37165502)

  • 1. Erucic Acid: A Possible Therapeutic Agent for Neurodegenerative Diseases.
    Goyal A; Dubey N; Verma A; Agrawal A
    Curr Mol Med; 2024; 24(4):419-427. PubMed ID: 37165502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism.
    Altinoz MA; Ozpinar A
    Int Immunopharmacol; 2019 Apr; 69():245-256. PubMed ID: 30738994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on neuropharmacological role of erucic acid: an omega-9 fatty acid from edible oils.
    Kumar JBS; Sharma B
    Nutr Neurosci; 2022 May; 25(5):1041-1055. PubMed ID: 33054628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis.
    Altinoz MA; Ozpinar A; Ozpinar A; Hacker E
    Metab Brain Dis; 2020 Jan; 35(1):1-9. PubMed ID: 31625071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of erucic acid on platelets in patients with adrenoleukodystrophy.
    Kickler TS; Zinkham WH; Moser A; Shankroff J; Borel J; Moser H
    Biochem Mol Med; 1996 Apr; 57(2):125-33. PubMed ID: 8733890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the potential pharmacological role of erucic acid: a monounsaturated omega-9 fatty acid.
    Kazmi I; Afzal M; Al-Abbasi FA; AlGhamdi SA; Alghamdi AM; Alzarea SI; Almalki WH; AlGhamdi AS; Alkinani KB; Sayyed N
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3663-3674. PubMed ID: 38060041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARδ and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease.
    Altinoz MA; Elmaci İ; Hacimuftuoglu A; Ozpinar A; Hacker E; Ozpinar A
    Mol Aspects Med; 2021 Apr; 78():100871. PubMed ID: 32703610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erucic acid, a component of Lorenzo's oil and PPAR-δ ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis.
    Altinoz MA; Bilir A; Elmaci İ
    Chem Biol Interact; 2018 Oct; 294():107-117. PubMed ID: 30142312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.
    Ahmed MA; Kartha RV; Brundage RC; Cloyd J; Basu C; Carlin BP; Jones RO; Moser AB; Fatemi A; Raymond GV
    Br J Clin Pharmacol; 2016 Jun; 81(6):1058-66. PubMed ID: 26836218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).
    Rasmussen M; Moser AB; Borel J; Khangoora S; Moser HW
    Neurochem Res; 1994 Aug; 19(8):1073-82. PubMed ID: 7800117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on rapeseed oil toxicology.
    Gatti GL; Michalek H
    Arzneimittelforschung; 1975 Oct; 25(10):1639-42. PubMed ID: 1243051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of alcohol on the metabolic conversion of 14C erucic acid in the liver of rats receiving rapeseed or peanut oil].
    Lecerf J; Bézard J
    J Physiol (Paris); 1975; 70(4):493-503. PubMed ID: 1221113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisomal oxidation of erucic acid suppresses mitochondrial fatty acid oxidation by stimulating malonyl-CoA formation in the rat liver.
    Chen X; Shang L; Deng S; Li P; Chen K; Gao T; Zhang X; Chen Z; Zeng J
    J Biol Chem; 2020 Jul; 295(30):10168-10179. PubMed ID: 32493774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
    Ferri R; Chance PF
    Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
    [No Abstract]   [Full Text] [Related]  

  • 19. [From Lorenzo's oil to myelin].
    Merminod A; Lemieux B
    Union Med Can; 1994 Jan; 123(1):36. PubMed ID: 8109065
    [No Abstract]   [Full Text] [Related]  

  • 20. Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid.
    Sassa T; Wakashima T; Ohno Y; Kihara A
    J Lipid Res; 2014 Mar; 55(3):524-30. PubMed ID: 24489110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.